Alpha9 Oncology develops radiotherapeutics for cancer treatment, focusing on peptide-based radiopharmaceuticals. The company aims to create targeted therapies for solid and hematologic malignancies.
investor of
Metrics
marketPRIVATE
msh_idCOM:ALPHA9TX
localeus
websitehttps://alpha9tx.com
source_refc6a0f466-8ed1-4d10-af68-0460178bc0ea
products_or_servicesDevelopment of radiopharmaceuticals for cancer treatment, targeting solid and hematologic malignancies
United States